In our study, results from multiple research methods illustrate that LAS induces cellular G2/M blockade to trigger apoptosis via downregulating the PLK1 pathway, which suggests LAS could be a promising therapeutic agent for treatment of breast cancer. This evidence concerns the gene PLK1 and breast carcinoma.